Dedicated Specialists




Bone Marrow Transplant Research

This listing changes frequently.  For more information about the trials we have available, please contact us at (551) 996-5627 or via e-mail pedsresearch@HackensackUMC.org
 
Pro00004687
Jennifer Krajewski, MD

Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial [PBMTC PROTOCOL GVH 1201]
 
00.05.187
Scott Rowley, MD

(Archive) Consent to submit Hematopoietic Stem Cell Transplant Data to Transplant Registries
 
Pro00002353
Alfred P. Gillio, MD

CBU:   A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
 
Pro00004217
Alfred P. Gillio, MD

BMT CTN 1202:  Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic Hematopoietic Cell Transplant (HCT)
 
Pro00004812
Jennifer Krajewski, MD

BMT CTN 1204:  Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies
 
Pro00002181
Alfred P. Gillio, MD

6901:  A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders (RDCRN PIDTC #6901)
 
Pro00002155
Alfred P. Gillio, MD
6902:  Primary Immune Deficiency Treatment Consortium RDCRN PIDTC Protocol #6902 (Inclusive V.2) A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID (1968-2010)
 
Pro00004748
Alfred P. Gillio, MD

6903:  Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995 
 
Pro00004610
Alfred P. Gillio,MD

6904: Analysis of Patients Treated for Wiskott-Aldrich Syndrome 
 
Pro00002300
Alfred P. Gillio, MD

MRD:  09-MRD:  The Role of Minimal Residual Disease Testing before and after Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia 
 
Pro00001152
Alfred P. Gillio, MD

Campath:  01-0923 A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced Intensity Preparatory Regime with Campath-1H, Fludarabine and Melphalan 
 
20140006 / II
Scott Rowley, MD

DAS181-2-05:  A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen 
 
Pro00000288
Alfred P. Gillio, MD

Defibrotide:  Defibrotide for Patients With Hepatic Veno-Occlusive Disease (VOD):  A Treatment IND Study (Under CFR 312.34)  
 
Pro00002002
Alfred P. Gillio, MD

Mesoblast:  Expanded Access of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GvHD (Prochymal) 
 
02.05.107
Scott Rowley, MD

Research Database for Hematopoietic Cell Transplantation and Cellular Therapies 
 
02.05.120
Scott Rowley, MD

Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation and Marrow Toxic Injury 
 
Pro00001894
Jennifer Krajewski, MD

Sickle Cell:  Reduced Intensity Stem Cell Transplantation for Sickle Cell Anemia in Patients 2-30 years old
 
Pro00005233
Jennifer Krajewski, MD

Post-transplant Cyclophosphamide as in vivo T cell depletion in Alternative Donor Bone Marrow Transplantation for Sickle Cell Anemia in Patients 2-19 years old
 


best-hospitals-cardiology    high-performing-indicator-heartfailure    high-performing-indicator-heartbypass     HG_Americas_50_Best_Award_Image_2014      HG_Americas_100_Best_Stroke_Care_Award_Image_2014        HG_Americas_100_Best_Pulmonary_Care_Award_Image_2014     red-bulllgbt      tkc_homepagelogo-2
 


Translation service provided by Google. Hackensack University Medical Center is not responsible for the accuracy of translation or any other
aspect of service provided by the GoogleTranslate tool. Users should not make medical decisions without first consulting
with their physician.
 
Site Map|Privacy Policy|Media Center
©2017 Hackensack University Medical Center. All rights reserved.
close (X)